Skip to main content

NovAccess Global Inc.

XSNXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001039466

NovAccess Global Inc. was delisted in 2026; its insiders filed their last Form 4 on Jun 4, 2024; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.

Holders of 5% or more of XSNX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NovAccess Global Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of NovAccess Global Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

8 Schedule 13D and 13G filings on NovAccess Global Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on XSNX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 18, 2024AJB Capital Investments LLC13G/AOld format–––SEC
Jun 11, 2024Sumner David13DOld format–New–SEC
Jan 18, 2024AJB Capital Investments LLC13GOld format–––SEC
Feb 23, 2023AJB Capital Investments LLC13GOld format–––SEC
May 17, 2022AJB Capital Investments LLC13GOld format–New–SEC
Mar 14, 2022Martin Daniel G.13D/AOld format–––SEC
Mar 14, 2022Morris-Irvin Dwain13D/AOld format–––SEC
Apr 16, 2021Morris-Irvin Dwain13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell NovAccess Global Inc. shares.

No Form 144 notices for NovAccess Global Inc. are on file.